Moderate Preservative Sensitization Data Dermal Penetration

Imidazolidinyl Urea

Also known as: EINECS 254-372-6, UNII-M629807ATL, N,N''-methylenebis(N'-(3-(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)urea), methanebis(N,N'-(5-ureido-2,4-diketotetrahydroimidazole)-N,N-dimethylol)

INCI: IMIDAZOLIDINYL UREA

Imidazolidinyl Urea (CAS 39236-46-9) is a cosmetic preservative functioning as Preservative; formaldehyde-releasing agent. EU Regulation 1223/2009 status: restricted, max 0.6%. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and pharmaceutical data.

View industrial chemical safety profile for CAS 39236-46-9 →

Auto-generated CPSR Part A draft with source citations
Function
Preservative; formaldehyde-releasing agent
Safety Rating
MODERATE

Chemistry & Identifiers

EC Number
254-372-6

Regulatory Status

EU EU Status restricted
EU Max Conc. 0.6%
US US Status permitted
US Notes Permitted; no concentration cap under FDA/MoCRA; associated with heavier microbial growth in mascara contamination studies

For full compliance data across multiple jurisdictions, use the Substance Compliance tool.

Safety Data

Margin of Safety, dermal absorption, and sensitization profile summaries for Imidazolidinyl Urea.

Calculate MoS for your specific formulation with the MoS Calculator.

Sensitization Profile

Contact sensitization data for Imidazolidinyl Urea based on clinical patch test studies and IFRA standards.

Sensitization Rate
moderate
Allergen Class
preservative
EU Allergen Listed
no
Patch Test Positive Rate
1.2%
Cross-reactivity Group
formaldehyde-releaser-group
Reaction Type
contact-dermatitis

Source: ESSCA 2019/20; IVDK; FDA

Dermal Penetration Profile

Skin absorption and penetration characteristics of Imidazolidinyl Urea, relevant to systemic exposure and MoS calculations.

Absorption %
1-3%
Penetration Level
surface
Penetration Depth
stratum corneum
Molecular Weight
388.3 Da
Log P
-3.2
Systemic Absorption
minimal
Topical Bioavailability
0.5-2%
Safety Margin Factor
low
Vehicle Dependent
Yes — absorption varies by formulation

Source: CIR

Sensitization AOP Dashboard

Adverse Outcome Pathway data across 5 assays (DPRA, KeratinoSens, hCLAT, LLNA, NESIL) aggregated from public sources.

DPRA Cys %
53.54%
DPRA Lys %
19.55%
KeratinoSens IC50
94.7 µM
hCLAT CV75
40.1 µg/mL
LLNA EC3
24%
NESIL
2500 µg/cm²
LLNA: Weak (1B) GHS: 1B Human: positive

Source: LLNA: Gerberick et al. (2005); DPRA: Joint Research Centre of the European Union 2013 | Gerberick et al. 2007 [DOI:10.1093/toxsci/kfm064]; KS: Emter et al. 2010 [DOI:10.1016/j.taap.2010.03.009] | Bauch et al. 2011 [DOI:10.1016/j.tiv.2011.05.030]; hCLAT: Urbisch et al. 2015 [DOI:10.1016/j.yrtph.2014.12.008] | Bauch et al. 2011 [DOI:10.1016/j.tiv.2011.05.030]; HPPT: [28] Jordan Jr WP and King SE (1977): https://doi.org/10.1111/j.1600-0536.1977.tb03582.x

HRIPT Human Patch Test Studies

3 human repeat insult patch tests aggregated from dermatological literature.

Test Type N Sensitized Dose µg/cm² NESIL µg/cm² Potency
HMT - 0 2500 - -
HRIPT - 0 2500 - -
OECD_DA_Human - 0 - - 1B (Weak sensitizer)

Endocrine Disruptor Evidence (Expanded)

Cross-referenced EDC classifications, mechanism data, and dose-response evidence from EDLists, SIN List, and cosmetic-specific detail sources.

Cosmetic-Specific Mechanism
Category: preservative
Receptor targets: ERα (formaldehyde releaser)
LOEC: N/A (indirect)
EU status: restricted (max 0.6% + labeling)

indirect (via formaldehyde)

Dose-Response Data Points
Endpoint Target Value Direction
ERα transcriptional activation (indirect via HCHO release) ERα (indirect) EC50/IC50: LOEC not precisely reported (~50 µM estimated); LOEC: ~50 µM (estimated); NOEC: not established mixed weak agonist
ARE-Nrf2 pathway activation; sensitization via HCHO release Nrf2/ARE pathway EC50/IC50: EC1.5 reported; potency lower than quaternium-15; LOEC: ~50 µg/mL (estimated from Danish EPA data); NOEC: not established mixed sensitizer
Thyroid peroxidase inhibition (indirect via HCHO) TPO (indirect via HCHO metabolite) EC50/IC50: No direct IC50; inhibitory capacity proportional to HCHO release rate; LOEC: not established; NOEC: not established mixed inhibitor (indirect, low potency)

ECHA REACH Registration

European Chemicals Agency REACH dossier and Substances of Very High Concern listing.

Registration Type
Full
Tonnage Band
100 - 1,000 tonnes
Substance Type
SUBSTANCE
SVHC Candidate
No

EU CosIng Annex Listing

European Commission CosIng database Annex references per Regulation (EC) No 1223/2009.

Annex V — Permitted Preservatives
Max: 0.6%

Expanded Jurisdictional Detail

Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.

KR Korea MFDS Annex 2 (Restricted)
Category: Preservative. Max: 0.6%. —
SA Saudi SFDA (V - Preservatives)
Max: 0.006.
JPKR Japan/Korea Cosmetics
Japan (Positive (Preservative)): max 0.30
Korea (Restricted): max 0.6%
BRIN Brazil/India Cosmetics
Brazil: Permitted Preservative · max 0,6%
India: Permitted Preservative · max 0.006
Additional Jurisdictional Restrictions (5)
Jurisdiction Status Max % Product Type
CN permitted_preservative 0.6 All cosmetics
IN permitted_preservative 0.6 all cosmetics
AU restricted 0.6 preservatives
BR permitted_preservative 0.6 -
ASEAN permitted_preservative 0.6% All products

Typical Use Concentrations

Reported concentration ranges per product category from SCCS/CIR/industry sources.

Product Category Typical Range Max Reported Source
Body Lotion 0.1–0.5 0.5 CIR

Additional Ingredient Properties

10 property records from structured ingredient metadata.

allergen_detail
{"eu_allergen_listed": "no", "allergen_class": "preservative", "cross_reactivity_group": "formaldehyde-releaser-group", "patch_test_frequency_pct": "1.2", "sensitization_rate": "moderate", "common_reaction_type": "contact-dermatitis", "ifra_restricted": "no", "source": "ESSCA 2019/20; IVDK; FDA"}
comedogenicity_detail
{"comedogenicity_rating": "0", "irritancy_rating": "3", "skin_type_suitability": "oily,combination", "acne_safe": "caution", "source": "Formaldehyde releaser"}
deodorant
{"cas_number": "39236-46-9", "ingredient_class": "antimicrobial_deodorant", "mechanism_of_action": "bacterial_growth_inhibition", "antiperspirant_efficacy_sweat_reduction_pct": "0", "deodorant_efficacy_hours": "24", "odor_reduction_pct": "60-80", "bacteriostatic": "yes", "bactericidal": "yes", "target_bacteria": "broad_spectrum", "microbiome_impact": "broad", "axillary_microbiome_effect": "varies …
dermal_absorption
{"molecular_weight_da": "388.3", "log_p_value": "-3.2", "skin_penetration_level": "surface", "penetration_depth": "stratum corneum", "absorption_pct": "1-3", "systemic_absorption": "minimal", "penetration_enhancer": "no", "occlusion_effect": "no", "vehicle_dependent": "yes", "skin_barrier_effect": "neutral", "bioavailability_topical_pct": "0.5-2", "safety_margin_factor": "low", "source": "CIR"}
microbiome_impact
{"microbiome_effect": "negative", "prebiotic": "no", "probiotic_compatible": "no", "antimicrobial_spectrum": "broad", "preservative_effect_on_microbiome": "Formaldehyde-releasing; bactericidal to S. epidermidis at <1 hour", "skin_flora_disruption": "severe", "gut_microbiome_risk": "low", "microbiome_recovery_time": "14-28 days", "selective_antimicrobial": "no", "pathogen_inhibition": "S. aureus, S…
pediatric_safety
{"safe_for_newborn_0_6m": "avoid", "safe_for_infant_6_12m": "caution", "safe_for_toddler_1_3y": "caution", "safe_for_child_3_12y": "yes", "safe_for_teen_12_18y": "yes", "pediatric_max_concentration_pct": "0.0", "adult_max_concentration_pct": "0.6", "pediatric_dermal_absorption_factor": "higher", "immature_skin_barrier_risk": "moderate", "oral_ingestion_risk": "moderate", "eye_irritation_risk": "mo…
ph_stability
{"optimal_ph_min": "4.0", "optimal_ph_max": "7.0", "stable_ph_min": "3.5", "stable_ph_max": "8.0", "degrades_above_ph": "8.5", "degrades_below_ph": "3.0", "ph_dependent_function": "Formaldehyde releaser", "formulation_note": "Similar to diazolidinyl urea", "source": "SpecialChem 2025"}
pregnancy_detail
{"pregnancy_safe": "avoid", "breastfeeding_safe": "avoid", "trimester_restriction": "all", "risk_category": "not-rated", "reason": "Formaldehyde releaser", "alternative_ingredient": "Phenoxyethanol; Sodium Benzoate", "source": "dermatology literature"}

Function Categories & List Membership

Cosmetic/Chemical Function Categories
Preservative Processing aids not otherwise specified
Regulatory List Membership (3)
EU Regulated in Personal Care EU Restricted for Children (Cosmetics) EU CosIng Cosmetics Ingredient Database

Expert Verdict

Expert safety assessment and concern-level summary for Imidazolidinyl Urea.

Regulatory Flags

preservative formaldehyde-releaser eu-annex-v eye-area sensitization-risk formaldehyde-release mascara-contamination-concern ocular-irritant eu_children_restricted eu_cosing_listed

Known Synonyms

EINECS 254-372-6 UNII-M629807ATL N,N''-methylenebis(N'-(3-(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)urea) methanebis(N,N'-(5-ureido-2,4-diketotetrahydroimidazole)-N,N-dimethylol)

Chemical Function

Preservative Processing aids not otherwise specified

Regulatory Lists

Europe; Personal care - body hygiene - hand soap children; Europe; Personal care children; Europe; Personal care - specialized bath products - bath salts children; Europe; Personal care - general moisturizing - hand/body lotion children; Europe; Personal care children; Europe; Personal care children; Europe; Personal care Europe; Personal care - deodorant Personal care - general moisturizing inert_ingredient; non_food_use; Pesticides Canada; pharmaceutical Canada; pharmaceutical Europe; Personal care active_ingredient; Europe; Pesticides

Australian Status

AICIS status: listed

Cross-Vertical Safety Context

Same-CAS public records found in pharmaceutical data.

SOURCE ChEMBL / DrugCentral / FAERS DB_PHARMA CAS match

Pharmaceutical Data

Same-CAS rows from the pharmaceutical spoke database.

Compound
IMIDUREA
ChEMBL ID
CHEMBL65433
Max Phase
-1
View full pharmaceutical profile →

Frequently Asked Questions

Is Imidazolidinyl Urea safe in cosmetics?

Imidazolidinyl Urea has a safety rating of "MODERATE" in our database. EU status: restricted. US status: permitted.

Is Imidazolidinyl Urea allowed in the EU?

Imidazolidinyl Urea EU regulatory status: restricted. Maximum allowed concentration: 0.6%. This is based on EU Regulation 1223/2009 and its amendments.

What does Imidazolidinyl Urea do in cosmetics?

Imidazolidinyl Urea functions as: Preservative; formaldehyde-releasing agent. It is classified as a Preservative in our database. CAS number: 39236-46-9.

Is Imidazolidinyl Urea used outside cosmetics?

Imidazolidinyl Urea also appears in industrial chemical safety and pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.

Is Imidazolidinyl Urea in Your Products?

Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.

Try Piro Free →

Analyze Your Full Ingredient List

Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Imidazolidinyl Urea in your formulation.